Technology to improve patient care: apply for contracts

Innovate UK

March 20
09:00 2017

NHS Scotland, working with Highlands and Islands Enterprise and Scottish Government, has up to 400,000 to invest in projects that use technology and digital platforms to support and manage inflammatory bowel disease.

Crohns disease and ulcerative colitis are collectively known as inflammatory bowel disease. They are lifelong conditions that affect 300,000 people across the UK and have a significant impact on life opportunities.

Treatment is traditionally given in outpatient clinics. For patients living in the north of Scotland this can mean regularly travelling long distances to access care.

Remote monitoring and better communication is seen as a way of improving patients lives.

The competition is looking for proposals that:

  • help patients manage their health from home
  • promote independence and support people to be more involved in decisions about their care
  • facilitate easier and quicker communication with clinicians

This competition is funded under SBRI (the Small Business Research Initiative) and will have 3 phases feasibility study, prototype development and pre-commercial testing.

Competition information

  • the competition opens on 20 March 2017, and the deadline for registration is at midday on 10 May 2017
  • the competition is open to any organisation that can demonstrate a route to market, working either alone or with partners
  • we expect feasibility projects to range in size to a total cost of 15,000 and to last up to 8 weeks
  • we expect prototype projects to range in size to a total cost of 45,000 and to last up to 6 months
  • we expect pre-commercial testing projects to range in size to a total cost of 75,000 and to last up to 1 year
  • projects will attract 100% funded development contracts
  • a briefing event will be held in Inverness on 4 April 2017

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: